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Connection between migraine and patent
foramen ovale (PFO) may be defined as
a “tower of Babel” or a “vexata quaestio.”
Indeed, there is still conflicting evidence
as to the causal relationship of PFO in
migraine with aura. The PFO is a kind of
oblique fissure between the right and the
left atrium, formed by the overlap of the
septum primum and the septum secun-
dum, guiding right-to-left shunt during
fetal life that bypass the lungs. When the
baby starts to breathe, the lungs expand
and there is a reduction in pulmonary pres-
sure, leading to closure of the shunt in
most cases. However, it does not close in
about 30% of cases, becoming a poten-
tial source of paradoxical embolism (1).
Migraine is a disabling condition charac-
terized by recurrent episodes of throbbing
headache associated with neuro-vegetative
symptoms, including nausea and vomiting,
photophobia, and phonophobia, which can
also be preceded by transient focal neu-
rological symptoms, like visual or sen-
sory/motor aura. Recently, PFO and its clo-
sure have aroused great interest, not only
in interventional cardiology, but also in
neurology. The frequency of PFO in the
population has been reported as 15–35%
(1). The life-time prevalence of migraine
ranges from 11% in males to 20% in
females, with an average of 16% (2). As
PFO and migraine are common condi-
tions, their co-occurrence might be coin-
cidental. However, the prevalence of right-
to-left shunt has been documented to be
significantly (at least twofold) higher in
patients suffering from migraine with aura
than in healthy controls. This suggests
that right-to-left shunt may play a role
both in the physiopathology of migraine
aura and the increased risk of stroke in
migraineurs. PFO accounts for 95% of all
right-to-left shunts (3). It has been postu-
lated that a right-to-left shunt may have a
causal relationship in migraine attacks with
aura. Microembolic paradox phenomena,
or serotoninergic metabolites from the
venous system, normally inactivated by
the pulmonary circulation, may trigger
migraine attacks through the induction
of cortical spreading depression, owing to
the right-to-left shunt (4). The connec-
tion between the right-to-left shunt and
migraine could also be explained by the
presence of transient hypoxic episodes,
caused by the blood shunting through
the PFO, determining micro-infarctions
resulting in migraine attacks (5). How-
ever, these hypotheses have many short-
comings and do not explain the PFO-
migraine nexus, as reported by Gupta (6)
and Sathasivam (7). As a rule, embolic
events show an unpredictable hemispheric
distribution (6), while migraine pain is typ-
ically lateralized, often periodic and pre-
dictable, like menstrual migraine. More-
over, unlike PFO, migraine is not mani-
fested at birth. Although migraineurs often
have episodes of remission and exacerba-
tion, PFO is not only life-long, but also
tends to increase in size with age (1), whilst
migraine decreases with aging. These con-
siderations are at odds with a possible link
between migraine and PFO. All of which
contrary to what one might expect if a PFO
was a causal factor in migraine. Indeed, in
the presence of a connection one might
well expect migraine not to be lateral-
ized, to be evident at birth and to worsen
with age. Patients suffering from migraine
frequently show white matter lesions on
MRI which may be correlated to hypo-
thetical paradoxical micro-embolisms able
to lead to micro-infarctions. However, it
has been documented that the right-to-
left shunt does not increase the burden of
white matter lesions (8), again against the
migraine/PFO nexus. The percutaneous
closure of septal defects with a left-to-right
shunt has been associated with improve-
ment of migraine (9). Several studies have
been carried out to determine whether clo-
sure of the PFO defect is able to affect
migraine frequency when the shunting is
predominantly right-to-left (10), even if
data from epidemiological studies on the
relationship between PFO and migraine are
controversial. Although non-randomized
studies have documented that migraine
attack frequency decreases after percuta-
neous closure of the right to left shunt,
to date, the only randomized study (11)
carried out on this (migraine intervention
with STARFlex® technology) did not con-
firm these results. Indeed, the primary end-
point of cessation of migraine at 6 months
post-treatment with percutaneous closure
showed no statistically significant differ-
ence between the two groups (in interven-
tion and control groups). Migraine/PFO
nexus might well represent only the result
of a common genetic substratum that, on
the one hand, could lead to a predispo-
sition to migraine and, on the other, to
endocardiac alteration with persistence of
the foramen ovale. A recent report docu-
mented that the occurrence of atrial shunts
was consistent with autosomal dominant
inheritance in some families with aura
migraine (12). Even if serendipity does play
a role in medicine advances, interpreta-
tion may be misleading in the absence of a
logically theoretical basis. Despite the the-
oretical possibility of PFO being at the root
of migraine, there is scant basic scientific
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and clinical evidence to support such a
theory. Moreover, the risks involved in PFO
closure must not be underestimated. Liter-
ature reports that up to 8% of surgical pro-
cedures may require transcatheter inter-
ventions to manage complications (13).
Serious complications, such as the forma-
tion of thrombus on the implant device,
thromboembolism related to the implant
device, cardiac perforation, infective endo-
carditis, or cardiac arrhythmias have also
been reported (13). Therefore, it may be
concluded that, currently, PFO closure is
not a recommended routine procedure to
prevent migraine. Not only is the patho-
physiological relevance of this procedure in
migraine treatment debatable, but its effi-
cacy has also been inconclusively proven.
Moreover, the complications of this proce-
dure may be serious and significant in com-
parison to the non-life threatening nature
of migraine. Further research on PFO in
migraine is clearly required before we may
consider changing opinion on the afore-
mentioned conclusions. Therefore, RCTs
cannot supplant or substitute good clini-
cal sense or justify serendipity. Neverthe-
less, the speculative links between migraine
and PFO continue to intrigue the med-
ical/research community. The best lesson
to be learnt from the history of medi-
cine might be that physicians’ enthusiasm
should be mitigated by the test of evi-
dence. Let us then strive to improve sci-
entific knowledge before changing clinical
practice.
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